Upstate Medical University is offering Mohs Micrographic
Surgery, an advanced skin cancer treatment that gives the highest possible
cure rate for many skin cancers while minimizing damage to normal tissue.
The surgery is primarily used to remove the two most common forms of skin
cancer, basal and squamous cell carcinomas, but can be used to treat less
common tumors including melanoma.
"Current estimates are that one in five Americans will develop skin cancer
in their lifetime," said Michael C. Iannuzzi, M.D., M.B.A., professor and
chair of Upstate s Department of Medicine. "The Upstate Medical
University Mohs Surgery Center is a much needed medical resource for the citizens of Central New York."
Ramsay-S. Farah, M.D., and his sister Joyce B. Farah, M.D., offer this
procedure through Upstate s Department of Medicine. Ramsay-S. Farah is an
associate professor of medicine and pathology and chief of the dermatology
division of the Department of Medicine and has boards in dermatopathology.
Joyce Farah is an assistant professor of medicine with fellowship training
in photodynamic therapy, a non-surgical treatment for pre-cancers and
non-melanoma skin cancers.
Mohs surgery is usually performed as an outpatient procedure. Local
anesthesia is administered around the area of the tumor allowing the patient
to remain awake throughout the procedure. The cure rates for Mohs
Micrographic Surgery approach 99 percent for most previously untreated
cancers with a slightly lower cure rate for secondary or recurrent
said Ramsay-S Farah.
Mohs surgery preserves the greatest amount of normal tissue, providing the
foundation for the best reconstructions and limiting scarring or permanent
disfigurement, according to Farah.
In Mohs surgery, the visible portion of the tumor is surgically removed. A
layer of the skin is removed and divided into sections that are color-coded
with dyes. The surgeon makes reference marks on the skin to show the source